MALFACINI, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.038
AS - Asia 259
EU - Europa 99
SA - Sud America 1
Totale 1.397
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.037
VN - Vietnam 123
SG - Singapore 69
CN - Cina 66
FR - Francia 30
IT - Italia 19
FI - Finlandia 11
GB - Regno Unito 11
DE - Germania 7
SE - Svezia 6
IE - Irlanda 5
NL - Olanda 4
BG - Bulgaria 3
RU - Federazione Russa 2
AR - Argentina 1
CA - Canada 1
JP - Giappone 1
UA - Ucraina 1
Totale 1.397
Salva come PNG Salva come JPEG
Città #
Fairfield 275
Dong Ket 123
Santa Clara 120
Seattle 74
Ashburn 59
San Diego 57
Woodbridge 54
Cambridge 50
Singapore 49
Boardman 38
Wilmington 36
Houston 34
Medford 32
Princeton 32
Roxbury 29
Beijing 20
Des Moines 16
Ann Arbor 13
Helsinki 10
Dublin 5
Legnaro 4
Chandler 3
Ferrara 3
Sofia 3
Bologna 2
London 2
Niederzier 2
Ogden 2
Prescot 2
Agordo 1
Bari 1
Borås 1
Chicago 1
Chiswick 1
Deventer 1
Hanover 1
Hounslow 1
Kharkiv 1
Kilburn 1
Lappeenranta 1
Las Vegas 1
Los Angeles 1
Negrar 1
New Bedfont 1
Norwalk 1
Novovarshavka 1
Padova 1
Philadelphia 1
Rockville 1
Rome 1
Rotterdam 1
Selvazzano Dentro 1
Southwark 1
Tokyo 1
Toronto 1
Xingtai 1
Zhoukou 1
Totale 1.177
Salva come PNG Salva come JPEG
Nome #
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 159
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 63
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 52
Novel Mixed NOP/Opioid Receptor Peptide Agonists 51
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 50
Pharmacological characterization of tachykinin tetrabranched derivatives 50
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 50
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 49
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 48
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 47
Pharmacological Assays for Investigating the NOP Receptor 46
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 46
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 46
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 46
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 41
Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity 41
Pharmacological characterization of naloxegol: In vitro and in vivo studies 40
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 39
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 39
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 38
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 38
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor 37
NOP receptor pharmacological profile – A dynamic mass redistribution study 37
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 35
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 35
Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues 35
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 27
Unraveling binding mechanism and kinetics of macrocyclic Gαq protein inhibitors 21
Heterologous Expression, Biosynthetic Studies, and Ecological Function of the Selective Gq-Signaling Inhibitor FR900359 21
GPCR in Adipose Tissue Function-Focus on Lipolysis 19
Lack of beta-arrestin signaling in the absence of active G proteins 19
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 18
Functional selectivity of EM-2 analogs at the mu-opioid receptor 15
Rational design of a heterotrimeric G protein subunit with artificial inhibitor sensitivity 13
(L)-Monomethyl Tyrosine (Mmt): New Synthetic Strategy via Bulky 'Forced-Traceless' Regioselective Pd-Catalyzed C(sp2)-H Activation 11
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors 9
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays 8
A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study 6
Totale 1.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.474
article - articoli 8.257
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 217
Totale 16.948
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021302 0 0 0 0 0 0 0 0 63 96 9 134
2021/2022623 21 36 34 60 13 10 14 81 15 8 133 198
2022/202376 47 1 2 0 2 6 0 2 1 0 6 9
2023/2024168 0 9 34 21 18 16 23 5 5 1 14 22
2024/2025276 1 54 40 24 157 0 0 0 0 0 0 0
Totale 1.445